Ralliant (NYSE:RAL) Updates Q3 2026 Earnings Guidance

Ralliant (NYSE:RAL) issued an update on its third quarter 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 0.720-0.780 for the period, compared to the consensus EPS estimate of 0.680. The company issued revenue guidance of $570.0 million-$590.0 million, compared to the consensus revenue estimate of $556.4 million. Ralliant also updated its FY 2026 guidance to 2.760-2.900 EPS.

Ralliant Stock Down 1.1%

Shares of RAL stock traded down $0.75 during mid-day trading on Friday, hitting $66.25. The stock had a trading volume of 814,572 shares, compared to its average volume of 1,709,292. Ralliant has a 12-month low of $37.27 and a 12-month high of $75.41. The firm has a market capitalization of $7.42 billion and a P/E ratio of -6.05. The firm’s 50-day moving average is $67.12 and its two-hundred day moving average is $54.26. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.61 and a quick ratio of 1.05.

Ralliant (NYSE:RAL) last posted its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.63 by $0.05. The business had revenue of $567.80 million for the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, analysts predict that Ralliant will post 2.64 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 8th were issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Monday, June 8th. Ralliant’s dividend payout ratio (DPR) is currently -1.83%.

Wall Street Analysts Forecast Growth

RAL has been the subject of a number of recent analyst reports. Wall Street Zen cut Ralliant from a “buy” rating to a “hold” rating in a research report on Sunday, July 26th. Oppenheimer increased their price target on Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Evercore initiated coverage on Ralliant in a research note on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 price target for the company. TD Cowen reissued a “buy” rating and issued a $80.00 price target (up from $70.00) on shares of Ralliant in a report on Friday. Finally, Vertical Research lowered Ralliant from a “buy” rating to a “hold” rating and set a $65.00 price target on the stock. in a research note on Wednesday, May 27th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Ralliant has a consensus rating of “Moderate Buy” and an average price target of $75.40.

Ralliant News Summary

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Truist raised its price target to $82 from $68 while reaffirming a Buy rating, implying approximately 24% upside from the referenced share price. Benzinga analyst rating report
• Positive Sentiment: Ralliant beat second-quarter expectations: adjusted EPS was $0.68 versus the $0.63 consensus estimate, while revenue reached approximately $568 million, up 13% year over year. Adjusted EBITDA margins and net earnings margins also improved year over year. Ralliant second-quarter 2026 results
• Positive Sentiment: Management raised its full-year 2026 outlook. Adjusted EPS guidance increased to $2.76-$2.90, above the $2.65 analyst consensus, while revenue guidance of roughly $2.25-$2.30 billion is also above prior expectations. Ralliant 2026 forecast and productivity program
• Positive Sentiment: Third-quarter guidance also exceeded expectations, with EPS projected at $0.72-$0.78 versus a $0.68 consensus and revenue of $570-$590 million versus $556.4 million expected. The company additionally targets $50-$60 million of annualized productivity savings by 2028.
• Neutral Sentiment: Trading in RAL was temporarily paused under a limit-up/limit-down (“LULD”) volatility halt on July 30. The halt itself does not change the company’s earnings outlook but indicates elevated short-term trading volatility.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Palisade Asset Management LLC acquired a new stake in shares of Ralliant during the 3rd quarter valued at about $26,000. BOKF NA acquired a new position in shares of Ralliant during the 3rd quarter worth approximately $29,000. Wilmington Savings Fund Society FSB purchased a new position in shares of Ralliant during the 3rd quarter valued at approximately $30,000. EverSource Wealth Advisors LLC acquired a new stake in Ralliant in the 2nd quarter valued at $39,000. Finally, NewEdge Advisors LLC acquired a new stake in Ralliant in the 2nd quarter valued at $43,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.